PhD/Microbiologist/Researcher
Microbiologist with expertise on the molecular mechanisms by which persistent pathogens modulate human gene expression, metabolism and immunity. Serves as PolyBio’s President, Research Director, and on the Board of Directors. Amy is an expert in conceptualizing and coordinating large-scale collaborative research projects. She has written multiple review articles that delineate core biological drivers of the LongCovid and ME/CFS disease processes. She holds a Bachelor of Science in biology from Georgetown University and a PhD in microbiology from Murdoch University in Australia.